Linda Hartman (L Hartman)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Top Venues

Rheumatology (Oxford, England)

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Linda Hartman, José A P da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Zoltan Szekanecz, Pavol Masaryk, Marieke J H Voshaar, Martijn W Heymans, Willem F Lems, Désirée M F M van der Heijde, Maarten Boers
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids. Rheumatology (Oxford, England) (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Linda Hartman, L A Rasch, S A Turk, M M Ter Wee, P J S M Kerstens, C J van der Laken, M T Nurmohamed, D van Schaardenburg, L H D van Tuyl, A E Voskuyl, M Boers, W F Lems
Favorable effect of a 'second hit' after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trial. Rheumatology (Oxford, England) (2022)
Linda Hartman, Maurizio Cutolo, Reinhard Bos, Daniela Opris-Belinski, Marc R Kok, Hanneke J R M Griep-Wentink, Ruth Klaasen, Cornelia F Allaart, George A W Bruyn, Hennie G Raterman, Marieke J H Voshaar, Nuno Gomes, Rui M A Pinto, L Thomas Klausch, Willem F Lems, Maarten Boers
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count. Rheumatology (Oxford, England) 60 (11) (2021)